Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00386581
Status:
COMPLETED
Last Update Posted:
2007-06-12
First Post:
2006-10-06
Brief Title:
Efficacy Tolerability and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-DeficitHyperactivity Disorder
Sponsor:
Organization:
Eli Lilly and Company